NCT00056446已完成3 期
A Randomized, Double-blind, Placebo-controlled, Phase III Study of Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo in Patients With Previously Treated Metastatic Adenocarcinoma of the Colon or Rectum
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 855
- 试验地点
- 143
- 主要终点
- Overall survival
研究概览
简要总结
The purpose of this study is to compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and whose disease has worsened after treatment with irinotecan.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
Oxaliplatin/5-FU/LV and PTK787/ZK 222584
干预措施: Vatalanib (Drug)
2
Placebo Comparator
Oxaliplatin/5-FU/LV and placebo
干预措施: Vatalanib (Drug)
结局指标
主要结局
Overall survival
时间窗: throughout duration of study
次要结局
- Tolerability and safety profile(throughout duration of study)
- Progression free survival(throughout duration of study)
- Time to progression(throughout duration of study)
- Tumor response rate(throughout duration of study)
- Time to treatment failure(throughout duration of study)
研究者
研究点 (143)
Loading locations...
相似试验
已完成
3 期
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.Colonic NeoplasmsRectal NeoplasmsColorectal NeoplasmsNCT00056459Novartis1,168
已完成
2 期
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With IrinotecanColorectal CancerNCT00016978National Cancer Institute (NCI)40
已完成
不适用
S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric CarcinomaStomach NeoplasmsNCT01364376Zhejiang University583
已完成
2 期
A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction AdenocarcinomaMetastatic Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaNCT02539225Eli Lilly and Company191
已完成
2 期
Oxaliplatin in Gastric CancerStomach NeoplasmsNCT00263354Sanofi20